Abstract:Background: The brain atrophy in individual Alzheimer's disease (AD) patients includes not only specific atrophy from AD pathology, but also atrophy induced by normal aging and cerebral vascular diseases. Although medial temporal lobe atrophy (MTA) together with CSF biomarkers is suggested to be the most important diagnostic markers for AD, it may not be specific. The current method of choice to measure MTA has been volumetric measurement based on 3D magnetic resonance imaging (MRI), but this complicated method has not been implemented clinically. Female sex has been suggested to be a risk factor for AD. The left hippocampus may be more vulnerable in AD. Atrophy of hippocampus has also been found to emerge in healthy adults, along with increased age. Purposes: To investigate whether simple Computerized Tomography (CT) linear measurements of brain could be of value in AD work-up; to create a normative database of hippocampus volume in our large population-based study and to examine if there is an acceleration of hippocampal atrophy in normal aging; to examine the hippocampal and entorhinal cortex volumes in relation to vascular risk factors. Material and Methods: In the CT study (Papers 1&2), 59 controls, 162 pure AD, and 86 AD with minor cerebrovascular changes (CVC) between the ages of 52 and 94 years were recruited from the Malmo Alzheimer Study. Abeta42, T-tau and P-tau in CSF were examined. CT linear measurements were performed, which included temporal horn ratio and suprasellar cistern ratio that reflect MTA. In the MRI study (Papers 3&4), 544 healthy non-demented subjects (aged 60-97 years) were recruited from the Swedish National study of Aging and Care in Kungsholmen (SNAC-K). Hippocampal formation and entorhinal cortex were manually delineated. Semi-automatic tools were used to access the volume of 3rd, lateral ventricle and intracranial volume (ICV). Vascular risk factors were collected. Results: In the CT study (Papers 1&2), temporal horn ratio and suprasellar cistern ratio were the atrophy factors that contributed most significantly to the diagnoses with correct AD classification of 90.2%. The correct classification of AD+CVC from controls increased from 79.5% (only CSF biomarkers) to 84.6% (combined CT measurements with CSF biomarkers). However, little was changed in the pure AD group. In the MRI study (Papers 3&4), The normalized volumes of hippocampus in males were smaller than that in females. The right hippocampus was larger than the left. The rate of aging atrophy trend (AAT) for the expansion of ventricles was larger than the estimated hippocampal shrinkage. The age point (72y) was shown to represent the time when the acceleration of AAT in hippocampus starts in normal aging. The score of vascular risk factors was significantly associated with reduced volumes of hippocampus and entorhinal cortex only among men. Conclusions: CT linear measurements could be of value in work-up of AD patients. Combined with the CT measure of MTA, the specificity of CSF biomarkers can be increased, but only in AD+CVC. In a non-demented elderly population, the females were more vulnerable to hippocampal atrophy. An acceleration of hippocampal atrophy may emerge and start around 72 years of age. An increasing burden of vascular risk factors is associated with reduced volume of hippocampus and entorhinal cortex.

Differential atrophy along the longitudinal hippocampal axis in Alzheimer's disease for the Alzheimer's Disease Neuroimaging Initiative

Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer's Disease: A Structural Imaging Study.

Progressive Volume Atrophy in Hippocampal Subfields and the Correlation with Cognition in Alzheimer’s Disease and Mild Cognitive Impairment

Progression of hippocampal subfield atrophy and asymmetry in Alzheimer's disease

Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer's disease spectrum

Atrophy of hippocampal subfields relates to memory decline during the pathological progression of Alzheimer's disease

Does Alzheimer’s Disease Affect Hippocampal Asymmetry? Evidence from a Cross-Sectional and Longitudinal Volumetric MRI Study

Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study

Differential Atrophy in the Hippocampal Subfield Volumes in Four Types of Mild Dementia

Morphometric analysis of medial temporal lobe subregions in Alzheimer's disease using high-resolution MRI

Volumetric changes within hippocampal subfields in Alzheimer’s disease continuum

Disentangling the heterogeneity of brain atrophy in Alzheimer’s Disease

Brain MRI and CT Morphology in Healthy Aging and Alzheimer's Disease

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization

Morphometric Analysis of Hippocampus and Lateral Ventricle Reveals Regional Difference Between Cognitively Stable and Declining Persons

The study of hippocampal metabolites level and volumetric changes in AD

Longitudinal Trajectory of Amyloid-related Hippocampal Subfield Atrophy in Nondemented Elderly.

Sex Differences in Grey Matter Atrophy Patterns among AD and Amci Patients: Results from ADNI.